David M. Jablons

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

David H. Johnson, Louis Fehrenbacher, William Novotny et al. · Journal of Clinical Oncology · 2004 · 1.9K citations · Full text

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Ashley Maynard, Caroline E. McCoach, Julia Rotow et al. · Cell · 2020 · 666 citations · Full text

Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion

Carolyn M. Dresler, Jemi Olak, James E. Herndon et al. · CHEST Journal · 2005 · 574 citations · Full text

Urology, Scleroderma, Pathology +6

SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

Biao He, Liang You, Kazutsugu Uematsu et al. · Proceedings of the National Academy of Sciences · 2003 · 376 citations · Full text

Immunology, Cell Death, Cancer Biology +21

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

Bin-Bing Zhou, Michael Peyton, Biao He et al. · Cancer Cell · 2006 · 375 citations · Full text

Tumor Biology, Adam-mediated Ligand Cleavage, Egfr Pathways +7